![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Siegfried Ltd Zofingen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Nitrendipine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-041 - Rev 01
This Chemical Type CEP, issued on October 28, 2009, remains in force until April 23, 2012, ensuring its reliability within the pharmaceutical industry.
Substance Number 1246 associated with this CEP further emphasizes